Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T cell-based strategies for HIV-1 vaccines
Bette Korber, Will Fischer
Human Vaccines & Immunotherapeutics (2019) Vol. 16, Iss. 3, pp. 713-722
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Prevention, treatment and cure of HIV infection
Raphael J. Landovitz, Hyman Scott, Steven G. Deeks
Nature Reviews Microbiology (2023) Vol. 21, Iss. 10, pp. 657-670
Closed Access | Times Cited: 79
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens
Will Fischer, Elena E. Giorgi, Srirupa Chakraborty, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1093-1110
Open Access | Times Cited: 90
HIV mRNA Vaccines—Progress and Future Paths
Zekun Mu, Barton F. Haynes, Derek W. Cain
Vaccines (2021) Vol. 9, Iss. 2, pp. 134-134
Open Access | Times Cited: 72
Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses
Zachary R. Stromberg, Will Fischer, Steven B. Bradfute, et al.
Vaccines (2020) Vol. 8, Iss. 2, pp. 273-273
Open Access | Times Cited: 37
Harnessing immune cells to eliminate HIV reservoirs
Paula Grasberger, Abigail R. Sondrini, Kiera Clayton
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 2, pp. 62-68
Open Access | Times Cited: 4
CD8+ T-cell responses in HIV controllers: potential implications for novel HIV remission strategies
Rachel L. Rutishauser, Lydie Trautmann
Current Opinion in HIV and AIDS (2022) Vol. 17, Iss. 5, pp. 315-324
Open Access | Times Cited: 18
A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials
Zoe Moodie, Shuying Sue Li, Elena E. Giorgi, et al.
Emerging Microbes & Infections (2025) Vol. 14, Iss. 1
Open Access
Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens
Chengcheng Zou, Hayato Murakoshi, Nozomi Kuse, et al.
Journal of Virology (2019) Vol. 93, Iss. 7
Open Access | Times Cited: 29
HIV-1 cure strategies: why CRISPR?
Andrew Atkins, Alexander G. Allen, Will Dampier, et al.
Expert Opinion on Biological Therapy (2020), pp. 1-13
Open Access | Times Cited: 25
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
Kristen W. Cohen, Andrew Fioré-Gartland, Stephen R. Walsh, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 4
Open Access | Times Cited: 8
A long-term stable cold-chain-friendly HIV mRNA vaccine encoding multi-epitope viral protease cleavage site immunogens inducing immunogen-specific protective T cell immunity
Subhra Mandal, Jayadri Sekhar Ghosh, Saroj Chandra Lohani, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials
Elahe Akbari, Masoud Seyedinkhorasani, Azam Bolhassani
The Brazilian Journal of Infectious Diseases (2023) Vol. 27, Iss. 3, pp. 102774-102774
Open Access | Times Cited: 7
Plant-made HIV vaccines and potential candidates
Jocelyne Trémouillaux‐Guiller, Khaled Moustafa, Kathleen Hefferon, et al.
Current Opinion in Biotechnology (2020) Vol. 61, pp. 209-216
Open Access | Times Cited: 19
In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes
Elahe Akbari, Kimia Kardani, Ali Namvar, et al.
Biotechnology Letters (2021)
Open Access | Times Cited: 16
New vector and vaccine platforms: mRNA, DNA, viral vectors
Tomáš Hanke
Current Opinion in HIV and AIDS (2022) Vol. 17, Iss. 6, pp. 338-344
Open Access | Times Cited: 12
Interventions during Early Infection: Opening a Window for an HIV Cure?
Christopher R. Hiner, April L. Mueller, Hang Su, et al.
Viruses (2024) Vol. 16, Iss. 10, pp. 1588-1588
Open Access | Times Cited: 2
Progress Towards a Therapeutic HIV DNA Vaccine
Paul V. Munson
Expert Review of Vaccines (2022) Vol. 21, Iss. 6, pp. 783-798
Closed Access | Times Cited: 10
Effect of epitope variant co-delivery on the depth of CD8 T cell responses induced by HIV-1 conserved mosaic vaccines
Edmund G. Wee, Nathifa Moyo, Zara Hannoun, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 21, pp. 741-753
Open Access | Times Cited: 14
Control of Simian Immunodeficiency Virus Infection in Prophylactically Vaccinated, Antiretroviral Treatment-Naive Macaques Is Required for the Most Efficacious CD8 T Cell Response during Treatment with the Interleukin-15 Superagonist N-803
Amy Ellis, Alexis J. Balgeman, Olivia E. Harwood, et al.
Journal of Virology (2022) Vol. 96, Iss. 20
Open Access | Times Cited: 9
Generating and measuring effective vaccine-elicited HIV-specific CD8+ T cell responses
Gina M. Borgo, Rachel L. Rutishauser
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 6, pp. 331-341
Open Access | Times Cited: 5
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes
Tatiana M. García-Bates, Mariana L. Palma, Renee R. Anderko, et al.
EBioMedicine (2021) Vol. 63, pp. 103175-103175
Open Access | Times Cited: 11
Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice
Chun‐Wei Chen, Narcı́s Saubi, Athina Kilpeläinen, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 15-15
Open Access | Times Cited: 8
Features of functional and dysfunctional CD8+ T cells to guide HIV vaccine development
Shaown Bhattacharyya, Charles R. Crain, Benjamin S. Goldberg, et al.
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 5, pp. 257-263
Open Access | Times Cited: 4
Dendritic cells in the treatment of HIV, cancer and systemic lupus erythematosus
Lenin Leonardo Bravo-Martínez, Moisés Talavera-Paulin
Proceedings of Scientific Research Universidad Anáhuac Multidisciplinary Journal of Healthcare (2024) Vol. 4, Iss. 7, pp. 23-33
Open Access | Times Cited: 1
Identification of a Clade-Specific HLA-C*03:02 CTL Epitope GY9 Derived from the HIV-1 p17 Matrix Protein
Samuel Kyobe, Savannah Mwesigwa, Gyaviira Nkurunungi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9683-9683
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top